| Device |
transurethral electrosurgical unit, benign prostatic hyperplasia |
| Regulation Description |
Endoscopic electrosurgical unit and accessories. |
| Definition |
Ablation of prostatic tissue for the treatment of benign prostatic hyperplasia. |
| Physical State |
The device consists primarily of a radio frequency generator and an applicator. The applicator is inserted into the urethra and positions the electrodes appropriately for delivery of RF energy transurethrally to the prostate. |
| Technical Method |
Radio frequency energy is applied to the prostate using electrodes. Resistive heating of the prostatic tissue leads to necrotic death or direct ablation depending on the temperatures achieved. |
| Target Area |
Prostate |
| Regulation Medical Specialty |
Gastroenterology/Urology |
| Review Panel |
General & Plastic Surgery |
| Product Code | OEJ |
| Submission Type |
510(k)
|
| Regulation Number |
876.4300
|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Guidance Document
- Guidance for Industry and Food and Drug Administration Staff - Guidance for the Non-Clinical and Clinical Investigation of Devices Used for the Treatment of Benign Prostatic Hyperplasia (BPH)
|
|
| Third Party Review |
Not Third Party Eligible |